Abstract
Brain metastases (BMs) account for a disproportionately high percentage of cancer morbidity and mortality. Historically, studies have focused on improving survival outcomes, and recent radiation oncology clinical trials have incorporated HRQOL and cognitive assessments. We are now equipped with a battery of assessments in the radiation oncology clinic, but there is a lack of consensus regarding how to incorporate them in modern clinical practice. Herein, we present validated assessments for BM patients, current recommendations for future clinical studies, and treatment advances that have improved HRQOL and cognitive outcomes for BM patients.
Original language | English |
---|---|
Article number | 4301 |
Journal | Cancers |
Volume | 14 |
Issue number | 17 |
DOIs | |
State | Published - Sep 2022 |
Externally published | Yes |
Keywords
- brain metastases
- cognition
- cognitive function
- quality of life
- radiotherapy